{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:13:47Z","timestamp":1791630827338,"version":"4.3.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004785","name":"Nordforsk","doi-asserted-by":"publisher","award":["#85352"],"award-info":[{"award-number":["#85352"]}],"id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019241","name":"CSC \u2013 IT Center for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005877","name":"Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["337660"],"award-info":[{"award-number":["337660"]}],"id":[{"id":"10.13039\/501100005877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The challenges associated with poorly water-soluble drugs have been recognized for several decades. Poor aqueous solubility directly impairs the bioavailability of a drug, but this can be significantly improved using a nanosuspension (NS) formulation strategy. In general, there is high variability in stabilizers that function with different drugs, and it is often difficult to predict which stabilizer will yield a stable NS formulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, poly(2-oxazine)- and poly(2-oxazoline)-based triblock copolymers (P1 and P2) were evaluated and benchmarked against commonly used stabilizers for the preparation of NS formulations, specifically hydroxypropyl methylcellulose and Pluronic F68. This study initiates the validation of P1 and P2 polymers for a new application, as these materials have not been previously studied as stabilizers in oral NS formulations. Indomethacin was selected as a poorly water-soluble model drug for NS preparation using a wet-ball milling technique. The stability of the resulting NSs was monitored over 28\u00a0days and their dissolution profiles were assessed under non-sink conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>P1 and P2 demonstrated better particle size reduction, and stability properties compared to the traditional stabilizers. In particular, P1 presented a marked improvement in the dissolution profiles of indomethacin, significantly outperforming the other NS formulations and reference samples. Molecular dynamics simulations further revealed distinct differences in the interactions of P1 and P2 with the indomethacin crystal surface, supporting the experimental findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our study highlights the potential of P1 as a promising stabilizer for nanosuspensions, providing mechanistic insights into polymer-drug compatibility, improved dissolution performance, and formulation stability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11095-026-04109-0","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:44:04Z","timestamp":1778859844000},"page":"1691-1709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Formulation and Evaluation of Indomethacin Nanosuspensions Stabilized by Poly(2-oxazine) and Poly(2-oxazoline)-Based Polymers for Solubility Enhancement"],"prefix":"10.1007","volume":"43","author":[{"given":"Erika","family":"Espo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Potdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Ke\u00dfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u0101rlis","family":"B\u0113rzi\u0146\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Kemell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Topias","family":"Kiiskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anni","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Kehrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben J.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi-Pekka","family":"Karttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Luxenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bunker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-9450","authenticated-orcid":false,"given":"Tapani","family":"Viitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"4109_CR1","first-page":"5","volume":"82","author":"CA Lipinski","year":"2002","unstructured":"Lipinski CA. Poor aqueous solubility - an industry wide problem in drug discovery. Am Pharm Rev. 2002;82:5.","journal-title":"Am Pharm Rev"},{"key":"4109_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.addr.2010.12.007","volume":"63","author":"E Merisko-Liversidge","year":"2011","unstructured":"Merisko-Liversidge E, Liversidge GG. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv Drug Deliv Rev. 2011;63:427\u201340. https:\/\/doi.org\/10.1016\/j.addr.2010.12.007.","journal-title":"Adv Drug Deliv Rev"},{"key":"4109_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.02.051","volume":"409","author":"I Ghosh","year":"2011","unstructured":"Ghosh I, Bose S, Vippagunta R, Harmon F. Pharmaceutical nanotechnology nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 2011;409:260\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.02.051.","journal-title":"Int J Pharm"},{"key":"4109_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.104967","volume":"137","author":"BJ Boyd","year":"2019","unstructured":"Boyd BJ, Bergstr\u00f6m CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019;137:104967. https:\/\/doi.org\/10.1016\/j.ejps.2019.104967.","journal-title":"Eur J Pharm Sci"},{"key":"4109_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","volume":"342","author":"H Park","year":"2022","unstructured":"Park H, Otte A, Park K. Evolution of drug delivery systems: from 1950 to 2020 and beyond. J Control Release. 2022;342:53\u201365. https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.030.","journal-title":"J Control Release"},{"key":"4109_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-020-0184-8","author":"S Jacob","year":"2020","unstructured":"Jacob S, Nair AB, Shah J. Emerging role of nanosuspensions in drug delivery systems. Biomater Res. 2020. https:\/\/doi.org\/10.1186\/s40824-020-0184-8.","journal-title":"Biomater Res"},{"key":"4109_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/10717544.2020.1856224","volume":"28","author":"J Li","year":"2021","unstructured":"Li J, Wang Z, Zhang H, Gao J, Zheng A. Progress in the development of stabilization strategies for nanocrystal preparations. Drug Deliv. 2021;28:19\u201336. https:\/\/doi.org\/10.1080\/10717544.2020.1856224.","journal-title":"Drug Deliv"},{"key":"4109_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.addr.2007.11.008","volume":"60","author":"J Wong","year":"2008","unstructured":"Wong J, Brugger A, Khare A, Chaubal M, Papadopoulos P, Rabinow B, et al. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Deliv Rev. 2008;60:939\u201354. https:\/\/doi.org\/10.1016\/j.addr.2007.11.008.","journal-title":"Adv Drug Deliv Rev"},{"key":"4109_CR9","doi-asserted-by":"publisher","first-page":"22286","DOI":"10.3390\/MOLECULES201219851","volume":"20","author":"L Peltonen","year":"2015","unstructured":"Peltonen L, Strachan C. Understanding critical quality attributes for nanocrystals from preparation to delivery. Molecules. 2015;20:22286\u2013300. https:\/\/doi.org\/10.3390\/MOLECULES201219851.","journal-title":"Molecules"},{"key":"4109_CR10","doi-asserted-by":"publisher","first-page":"6928","DOI":"10.1021\/ACS.CGD.2C00546","volume":"22","author":"F Hl\u00e1dek","year":"2022","unstructured":"Hl\u00e1dek F, Chv\u00edla S, Navr\u00e1til O, Balouch M, \u0160t\u011bp\u00e1nek F. Systematic investigation of wet-milling kinetics and colloidal stability of pharmaceutical nanocrystals. Cryst Growth Des. 2022;22:6928\u201340. https:\/\/doi.org\/10.1021\/ACS.CGD.2C00546.","journal-title":"Cryst Growth Des"},{"key":"4109_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10080927","volume":"10","author":"Y Pirincci Tok","year":"2023","unstructured":"Pirincci Tok Y, Mesut B, G\u00fcng\u00f6r S, Sar\u0131kaya AO, Aldeniz EE, Dude U, et al. Systematic screening study for the selection of proper stabilizers to produce physically stable canagliflozin nanosuspension by wet milling method. Bioengineering. 2023;10:927. https:\/\/doi.org\/10.3390\/bioengineering10080927.","journal-title":"Bioengineering"},{"key":"4109_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/J.IJPHARM.2011.03.050","volume":"411","author":"P Liu","year":"2011","unstructured":"Liu P, Rong X, Laru J, Van Veen B, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215\u201322. https:\/\/doi.org\/10.1016\/J.IJPHARM.2011.03.050.","journal-title":"Int J Pharm"},{"key":"4109_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ejpb.2016.07.006","volume":"107","author":"M Karashima","year":"2016","unstructured":"Karashima M, Kimoto K, Yamamoto K, Kojima T, Ikeda Y. A novel solubilization technique for poorly soluble drugs through the integration of nanocrystal and cocrystal technologies. Eur J Pharm Biopharm. 2016;107:142\u201350. https:\/\/doi.org\/10.1016\/j.ejpb.2016.07.006.","journal-title":"Eur J Pharm Biopharm"},{"key":"4109_CR14","doi-asserted-by":"publisher","unstructured":"Haider MS, Luxenhofer R. Development of poly(2-oxazoline)s and poly(2-oxazine)s based formulation library and estimation of polymer\/drug compatibility. Preprint at ChemRxiv (2022); https:\/\/doi.org\/10.26434\/chemrxiv-2022-s8xc3","DOI":"10.26434\/chemrxiv-2022-s8xc3"},{"key":"4109_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1021\/ACSAPM.2C01845","volume":"5","author":"L Ke\u00dfler","year":"2023","unstructured":"Ke\u00dfler L, Mirzaei Z, Kade JC, Luxenhofer R. Highly porous and drug-loaded amorphous solid dispersion microfiber scaffolds of indomethacin prepared by melt electrowriting. ACS Appl Polym Mater. 2023;5:913\u201322. https:\/\/doi.org\/10.1021\/ACSAPM.2C01845.","journal-title":"ACS Appl Polym Mater"},{"key":"4109_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.MOLPHARMACEUT.4C00086","author":"J Kehrein","year":"2024","unstructured":"Kehrein J, Bunker A, Luxenhofer R. POxload: machine learning estimates drug loadings of polymeric micelles. Mol Pharm. 2024. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.4C00086.","journal-title":"Mol Pharm"},{"key":"4109_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/MABI.201800155","volume":"18","author":"MM L\u00fcbtow","year":"2018","unstructured":"L\u00fcbtow MM, Ke\u00dfler L, Appelt-Menzel A, Lorson T, Gangloff N, Kirsch M, et al. More is sometimes less: curcumin and paclitaxel formulations using poly(2-oxazoline) and poly(2-oxazine)-based amphiphiles bearing linear and branched C9 side chains. Macromol Biosci. 2018;18:1800155. https:\/\/doi.org\/10.1002\/MABI.201800155.","journal-title":"Macromol Biosci"},{"key":"4109_CR18","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1016\/J.BIOMATERIALS.2010.02.057","volume":"31","author":"R Luxenhofer","year":"2010","unstructured":"Luxenhofer R, Schulz A, Roques C, Li S, Bronich TK, Batrakova EV, et al. Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials. 2010;31:4972\u20139. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2010.02.057.","journal-title":"Biomaterials"},{"key":"4109_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/J.JCIS.2021.08.040","volume":"606","author":"S Endres","year":"2022","unstructured":"Endres S, Karaev E, Hanio S, Schlauersbach J, Kraft C, Rasmussen T, et al. Concentration and composition dependent aggregation of Pluronic- and poly-(2-oxazolin)-efavirenz formulations in biorelevant media. J Colloid Interface Sci. 2022;606:1179\u201392. https:\/\/doi.org\/10.1016\/J.JCIS.2021.08.040.","journal-title":"J Colloid Interface Sci"},{"key":"4109_CR20","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1021\/ACSBIOMATERIALS.3C00645","volume":"9","author":"S Endres","year":"2023","unstructured":"Endres S, Ehrmanntraut S, Endres L, Can K, Kraft C, Rasmussen T, et al. Structural investigation on how guest loading of poly(2-oxazoline)-based micelles affects the interaction with simulated intestinal fluids. ACS Biomater Sci Eng. 2023;9:4821\u201330. https:\/\/doi.org\/10.1021\/ACSBIOMATERIALS.3C00645.","journal-title":"ACS Biomater Sci Eng"},{"key":"4109_CR21","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/MABI.201200080","volume":"12","author":"HPC Van Kuringen","year":"2012","unstructured":"Van Kuringen HPC, Lenoir J, Adriaens E, Bender J, De Geest BG, Hoogenboom R. Partial hydrolysis of poly(2-ethyl-2-oxazoline) and potential implications for biomedical applications? Macromol Biosci. 2012;12:1114\u201323. https:\/\/doi.org\/10.1002\/MABI.201200080.","journal-title":"Macromol Biosci"},{"key":"4109_CR22","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","volume":"35","author":"J Ulbricht","year":"2014","unstructured":"Ulbricht J, Jordan R, Luxenhofer R. On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s. Biomaterials. 2014;35:4848\u201361. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.02.029.","journal-title":"Biomaterials"},{"key":"4109_CR23","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.5793990.v1","author":"Z Kronekov\u00e1","year":"2018","unstructured":"Kronekov\u00e1 Z, Lorson T, Kronek J, Luxenhofer R. Cytotoxicity of 2-oxazines and poly(2-oxazine)s in mouse fibroblast. ChemRxiv. 2018. https:\/\/doi.org\/10.26434\/chemrxiv.5793990.v1.","journal-title":"ChemRxiv"},{"key":"4109_CR24","doi-asserted-by":"publisher","unstructured":"Luxenhofer R, Han Y, Schulz A, Tong J, He Z, Kabanov AV, et al. Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun. 2012(19). https:\/\/doi.org\/10.1002\/marc.201200354.","DOI":"10.1002\/marc.201200354"},{"key":"4109_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.06.002","volume":"101","author":"Z He","year":"2016","unstructured":"He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, et al. A high capacity polymeric micelle of paclitaxel: implication of high dose drug therapy to safety and in vivo anti-cancer activity. Biomaterials. 2016;101:296. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.002.","journal-title":"Biomaterials"},{"key":"4109_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOMATERIALS.2021.121140","volume":"278","author":"D Hwang","year":"2021","unstructured":"Hwang D, Vinod N, Skoczen SL, Ramsey JD, Snapp KS, Montgomery SA, et al. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane\u00ae in rodent and non-human primate models using a stable isotope tracer assay. Biomaterials. 2021;278:121140. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2021.121140.","journal-title":"Biomaterials"},{"key":"4109_CR27","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1021\/acs.biomac.7b00481","volume":"18","author":"T Lorson","year":"2017","unstructured":"Lorson T, Jaksch S, L\u00fcbtow MM, J\u00fcngst T, Groll J, L\u00fchmann T, et al. A thermogelling supramolecular hydrogel with sponge-like morphology as a cytocompatible bioink. Biomacromolecules. 2017;18:2161\u201371. https:\/\/doi.org\/10.1021\/acs.biomac.7b00481.","journal-title":"Biomacromolecules"},{"key":"4109_CR28","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.molpharmaceut.9b01117","volume":"17","author":"MM L\u00fcbtow","year":"2020","unstructured":"L\u00fcbtow MM, Oerter S, Quader S, Jeanclos E, Jeanclos E, Cubukova A, et al. In vitro blood\u2013brain barrier permeability and cytotoxicity of an atorvastatin-loaded nanoformulation against glioblastoma in 2D and 3D models. Mol Pharm. 2020;17:1835\u201347. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.9b01117.","journal-title":"Mol Pharm"},{"key":"4109_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jconrel.2019.04.014","volume":"303","author":"MM L\u00fcbtow","year":"2019","unstructured":"L\u00fcbtow MM, Nelke LC, Seifert J, K\u00fchnemundt J, Sahay G, Dandekar G, et al. Drug induced micellization into ultra-high capacity and stable curcumin nanoformulations: physico-chemical characterization and evaluation in 2D and 3D in vitro models. J Control Release. 2019;303:162\u201380. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.014.","journal-title":"J Control Release"},{"key":"4109_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/MABI.202200056","author":"JD Ramsey","year":"2022","unstructured":"Ramsey JD, Stewart IE, Madden EA, Lim C, Hwang D, Heise MT, et al. Nanoformulated remdesivir with extremely low content of poly(2-oxazoline)-based stabilizer for aerosol treatment of COVID-19. Macromol Biosci. 2022. https:\/\/doi.org\/10.1002\/MABI.202200056.","journal-title":"Macromol Biosci"},{"key":"4109_CR31","unstructured":"Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product. European Medicines Agency; 2008. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-excipients-dossier-application-marketing-authorisation-medicinal-product-revision-2_en.pdf."},{"key":"4109_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/J.IJPHARM.2017.07.028","volume":"529","author":"V Garc\u00eda-Herrero","year":"2017","unstructured":"Garc\u00eda-Herrero V, Torrado C, Garc\u00eda-Rodr\u00edguez JJ, L\u00f3pez-S\u00e1nchez A, Torrado S, Torrado-Santiago S. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: in vitro and in vivo studies. Int J Pharm. 2017;529:381\u201390. https:\/\/doi.org\/10.1016\/J.IJPHARM.2017.07.028.","journal-title":"Int J Pharm"},{"key":"4109_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.IJPHARM.2014.02.043","volume":"467","author":"P Madelung","year":"2014","unstructured":"Madelung P, Ostergaard J, Bertelsen P, J\u00f8rgensen EV, Jacobsen J, M\u00fcllertz A. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs. Int J Pharm. 2014;467:1\u20138. https:\/\/doi.org\/10.1016\/J.IJPHARM.2014.02.043.","journal-title":"Int J Pharm"},{"key":"4109_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/10837450.2015.1022788","volume":"21","author":"E Bilgili","year":"2016","unstructured":"Bilgili E, Li M, Afolabi A. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS class II drug nanosuspensions? Pharm Dev Technol. 2016;21:499\u2013510. https:\/\/doi.org\/10.3109\/10837450.2015.1022788.","journal-title":"Pharm Dev Technol"},{"key":"4109_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2025.125188","volume":"671","author":"L Ke\u00dfler","year":"2025","unstructured":"Ke\u00dfler L, Luxenhofer R. Melt electrowriting of amorphous solid dispersions: influence of drug and plasticizer on rheology and printing performance. Int J Pharm. 2025;671:125188. https:\/\/doi.org\/10.1016\/J.IJPHARM.2025.125188.","journal-title":"Int J Pharm"},{"key":"4109_CR36","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1208\/s12249-013-9960-2","volume":"14","author":"P Liu","year":"2013","unstructured":"Liu P, De Wulf O, Laru J, Heikkil\u00e4 T, Van Veen B, Kiesvaara J, et al. Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions. AAPS PharmSciTech. 2013;14:748\u201356. https:\/\/doi.org\/10.1208\/s12249-013-9960-2.","journal-title":"AAPS PharmSciTech"},{"key":"4109_CR37","unstructured":"Schr\u00f6dinger Release 2025\u20132: Maestro, Schr\u00f6dinger, LLC, New York, NY. BioLuminate, Schr\u00f6dinger, LLC; 2025.\u00a0https:\/\/www.schrodinger.com\/citations\/."},{"key":"4109_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeerschd T, Zurek E, Hutchison GR. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform. 2012;4:1\u201317. https:\/\/doi.org\/10.1186\/1758-2946-4-17.","journal-title":"J Cheminform"},{"key":"4109_CR39","doi-asserted-by":"publisher","DOI":"10.2477\/JCCJIE.2018-0034","volume":"5","author":"M Yabe","year":"2019","unstructured":"Yabe M, Mori K, Ueda K, Takeda M. Development of PolyParGen software to facilitate the determination of molecular dynamics simulation parameters for polymers. J Comput Chem Jpn Int Ed. 2019;5:2018\u20130034. https:\/\/doi.org\/10.2477\/JCCJIE.2018-0034.","journal-title":"J Comput Chem Jpn Int Ed"},{"key":"4109_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/NAR\/GKX312","volume":"45","author":"LS Dodda","year":"2017","unstructured":"Dodda LS, De Vaca IC, Tirado-Rives J, Jorgensen WL. LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands. Nucleic Acids Res. 2017;45:331\u20136. https:\/\/doi.org\/10.1093\/NAR\/GKX312.","journal-title":"Nucleic Acids Res"},{"key":"4109_CR41","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/JCC.20297","volume":"26","author":"WL Jorgensen","year":"2005","unstructured":"Jorgensen WL, Tirado-Rives J. Molecular modeling of organic and biomolecular systems using BOSS and MCPRO. J Comput Chem. 2005;26:1689\u2013700. https:\/\/doi.org\/10.1002\/JCC.20297.","journal-title":"J Comput Chem"},{"key":"4109_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/J.SOFTX.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/J.SOFTX.2015.06.001.","journal-title":"SoftwareX"},{"key":"4109_CR43","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys. 2007. https:\/\/doi.org\/10.1063\/1.2408420.","journal-title":"J Chem Phys"},{"key":"4109_CR44","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1107\/S160053680301290X","volume":"59","author":"PJ Cox","year":"2003","unstructured":"Cox PJ, Manson PL. \u03b3-Indomethacin at 120 K. Acta Crystallogr Sect E Struct Rep Online. 2003;59:986\u20138. https:\/\/doi.org\/10.1107\/S160053680301290X.","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"4109_CR45","unstructured":"The PyMOL molecular graphics system, Version 2.0. Schrodinger, LLC.\u00a0https:\/\/www.pymol.org\/support.html?#citing."},{"key":"4109_CR46","doi-asserted-by":"publisher","unstructured":"Kohlmeyer A, Vermaas J, Braun E. akohlmey\/topotools: Release 1.9. 2022. https:\/\/doi.org\/10.5281\/ZENODO.7071898","DOI":"10.5281\/ZENODO.7071898"},{"key":"4109_CR47","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79:926\u201335. https:\/\/doi.org\/10.1063\/1.445869.","journal-title":"J Chem Phys"},{"key":"4109_CR48","doi-asserted-by":"publisher","DOI":"10.1063\/5.0020514","author":"M Bernetti","year":"2020","unstructured":"Bernetti M, Bussi G. Pressure control using stochastic cell rescaling. J Chem Phys. 2020. https:\/\/doi.org\/10.1063\/5.0020514.","journal-title":"J Chem Phys"},{"key":"4109_CR49","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.JCTC.8B00765","volume":"14","author":"KJ Boyd","year":"2018","unstructured":"Boyd KJ, May ER. BUMPy: a model-independent tool for constructing lipid bilayers of varying curvature and composition. J Chem Theory Comput. 2018;14:6642. https:\/\/doi.org\/10.1021\/ACS.JCTC.8B00765.","journal-title":"J Chem Theory Comput"},{"key":"4109_CR50","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden T, York D, Pedersen L. Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems. J Chem Phys. 1993;98:10089\u201392. https:\/\/doi.org\/10.1063\/1.464397.","journal-title":"J Chem Phys"},{"key":"4109_CR51","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463\u201372. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H.","journal-title":"J Comput Chem"},{"key":"4109_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33\u20138. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5.","journal-title":"J Mol Graph"},{"key":"4109_CR53","doi-asserted-by":"publisher","unstructured":"Gowers R, Linke M, Barnoud J, Reddy T, Melo M, Seyler S, et al. MDAnalysis: A python package for the rapid analysis of molecular dynamics simulations. Proceedings of the 15th Python in Science Conference. 2016;98\u2013105. https:\/\/doi.org\/10.25080\/MAJORA-629E541A-00E","DOI":"10.25080\/MAJORA-629E541A-00E"},{"key":"4109_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpb.2016.03.007","volume":"103","author":"PT Mah","year":"2016","unstructured":"Mah PT, Peltonen L, Novakovic D, Rades T, Strachan CJ, Laaksonen T. The effect of surfactants on the dissolution behavior of amorphous formulations. Eur J Pharm Biopharm. 2016;103:13\u201322. https:\/\/doi.org\/10.1016\/j.ejpb.2016.03.007.","journal-title":"Eur J Pharm Biopharm"},{"key":"4109_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijpharm.2018.02.002","volume":"540","author":"MB Rask","year":"2018","unstructured":"Rask MB, Knopp MM, Olesen NE, Holm R, Rades T. Comparison of two DSC-based methods to predict drug-polymer solubility. Int J Pharm. 2018;540:98\u2013105. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.002.","journal-title":"Int J Pharm"},{"key":"4109_CR56","doi-asserted-by":"publisher","first-page":"9002","DOI":"10.1063\/1.459240","volume":"93","author":"CL Jackson","year":"1990","unstructured":"Jackson CL, McKenna GB. The melting behavior of organic materials confined in porous solids. J Chem Phys. 1990;93:9002\u201311. https:\/\/doi.org\/10.1063\/1.459240.","journal-title":"J Chem Phys"},{"key":"4109_CR57","doi-asserted-by":"publisher","DOI":"10.22270\/JDDT.V8I3.1727","author":"CH Luis","year":"2018","unstructured":"Luis CH, German MR, Rolando VZ, Gustavo CB. Combined use of DSC, TGA, XDR and NIR in the compatibility study of preformulation mixtures for the development of 10 mg tablets of rupatadine fumarate. J Drug Deliv Ther. 2018. https:\/\/doi.org\/10.22270\/JDDT.V8I3.1727.","journal-title":"J Drug Deliv Ther"},{"key":"4109_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejps.2007.07.003","volume":"32","author":"A Heinz","year":"2007","unstructured":"Heinz A, Savolainen M, Rades T, Strachan CJ. Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy. Eur J Pharm Sci. 2007;32:182\u201392. https:\/\/doi.org\/10.1016\/j.ejps.2007.07.003.","journal-title":"Eur J Pharm Sci"},{"key":"4109_CR59","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1021\/ACS.MOLPHARMACEUT.2C00126","volume":"19","author":"J Koskela","year":"2022","unstructured":"Koskela J, Sutton JJ, Lipi\u00e4inen T, Gordon KC, Strachan CJ, Fraser-Miller SJ. Low-versus mid-frequency Raman spectroscopy for in situ analysis of crystallization in slurries. Mol Pharm. 2022;19:2316\u201326. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.2C00126.","journal-title":"Mol Pharm"},{"key":"4109_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejps.2009.06.007","volume":"38","author":"A H\u00e9doux","year":"2009","unstructured":"H\u00e9doux A, Paccou L, Guinet Y, Willart JF, Descamps M. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin. Eur J Pharm Sci. 2009;38:156\u201364. https:\/\/doi.org\/10.1016\/j.ejps.2009.06.007.","journal-title":"Eur J Pharm Sci"},{"key":"4109_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2012\/892806","volume":"2012","author":"E Atef","year":"2012","unstructured":"Atef E, Chauhan H, Prasad D, Kumari D, Pidgeon C. Quantifying solid-state mixtures of crystalline indomethacin by Raman spectroscopy comparison with thermal analysis. ISRN Chromatogr. 2012;2012:1\u20136. https:\/\/doi.org\/10.5402\/2012\/892806.","journal-title":"ISRN Chromatogr"},{"key":"4109_CR62","unstructured":"Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press; 2006."},{"key":"4109_CR63","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1002\/jps.20802","volume":"96","author":"L Zema","year":"2007","unstructured":"Zema L, Maroni A, Foppoli A, Palugan L, Sangalli ME, Gazzaniga A. Different HPMC viscosity grades as coating agents for an oral time and\/or site-controlled delivery system: an investigation into the mechanisms governing drug release. J Pharm Sci. 2007;96:1527\u201336. https:\/\/doi.org\/10.1002\/jps.20802.","journal-title":"J Pharm Sci"},{"key":"4109_CR64","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ijpharm.2017.10.063","volume":"535","author":"Z Huang","year":"2017","unstructured":"Huang Z, Parikh S, Fish WP. Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact on in vitro dissolution behavior. Int J Pharm. 2017;535:350\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.10.063.","journal-title":"Int J Pharm"},{"key":"4109_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejps.2005.05.008","volume":"26","author":"V Gallardo","year":"2005","unstructured":"Gallardo V, Morales ME, Ruiz MA, Delgado AV. An experimental investigation of the stability of ethylcellulose latex: correlation between zeta potential and sedimentation. Eur J Pharm Sci. 2005;26:170\u20135. https:\/\/doi.org\/10.1016\/j.ejps.2005.05.008.","journal-title":"Eur J Pharm Sci"},{"key":"4109_CR66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/J.IJPHARM.2014.01.013","volume":"464","author":"S Kumar","year":"2014","unstructured":"Kumar S, Xu X, Gokhale R, Burgess DJ. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach. Int J Pharm. 2014;464:34\u201345. https:\/\/doi.org\/10.1016\/J.IJPHARM.2014.01.013.","journal-title":"Int J Pharm"},{"key":"4109_CR67","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1021\/ACS.MOLPHARMACEUT.3C00442\/","volume":"20","author":"A Aljabbari","year":"2023","unstructured":"Aljabbari A, Kihara S, Rades T, Boyd BJ, Be\u0305rzi\u0146\u0161 K. The influence of gastrointestinal biomolecules on solid-state transformations in pharmaceutical particulates. Mol Pharm. 2023;20:4297\u2013306. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.3C00442\/.","journal-title":"Mol Pharm"},{"key":"4109_CR68","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejpb.2015.05.028","volume":"94","author":"M Azad","year":"2015","unstructured":"Azad M, Afolabi A, Bhakay A, Leonardi J, Dav\u00e9 R, Bilgili E. Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer. Eur J Pharm Biopharm. 2015;94:372\u201385. https:\/\/doi.org\/10.1016\/j.ejpb.2015.05.028.","journal-title":"Eur J Pharm Biopharm"},{"key":"4109_CR69","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2014.11.043","volume":"478","author":"Z Buj","year":"2014","unstructured":"Buj Z, Dutkov\u00e1 E, Bal\u00e1\u017e M, Turianicov\u00e1 E, Bal\u00e1\u017e P. Pharmaceutical nanotechnology stability studies of As4S4 nanosuspension prepared by wet milling in Poloxamer 407. Int J Pharm. 2014;478:187\u201392. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.11.043.","journal-title":"Int J Pharm"},{"key":"4109_CR70","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijpharm.2018.05.020","volume":"546","author":"T Wang","year":"2018","unstructured":"Wang T, Qi J, Ding N, Dong X, Zhao W, Lu Y, et al. Tracking translocation of self-discriminating curcumin hybrid nanocrystals following intravenous delivery. Int J Pharm. 2018;546:10\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.05.020.","journal-title":"Int J Pharm"},{"key":"4109_CR71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0168-3659(02)00009-3","volume":"82","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY. Pluronic\u00ae block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189\u2013212. https:\/\/doi.org\/10.1016\/S0168-3659(02)00009-3.","journal-title":"J Control Release"},{"key":"4109_CR72","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1021\/ACS.MOLPHARMACEUT.2C00634","volume":"20","author":"OAO M\u00fcllertz","year":"2023","unstructured":"M\u00fcllertz OAO, Andersen P, Christensen D, Foged C, Thakur A. Pulmonary administration of the liposome-based adjuvant CAF01: effect of surface charge on mucosal adjuvant function. Mol Pharm. 2023;20:953\u201370. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.2C00634.","journal-title":"Mol Pharm"},{"key":"4109_CR73","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1021\/ACS.MOLPHARMACEUT.7B00611","volume":"14","author":"L Chen","year":"2017","unstructured":"Chen L, Simpson JD, Fuchs AV, Rolfe BE, Thurecht KJ. Effects of surface charge of hyperbranched polymers on cytotoxicity, dynamic cellular uptake and localization, hemotoxicity, and pharmacokinetics in mice. Mol Pharm. 2017;14:4485\u201397. https:\/\/doi.org\/10.1021\/ACS.MOLPHARMACEUT.7B00611.","journal-title":"Mol Pharm"},{"key":"4109_CR74","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1021\/acs.nanolett.2c01316","volume":"22","author":"Y Shi","year":"2022","unstructured":"Shi Y, Xu X, Yu H, Lin Z, Zuo H, Wu Y. Defined positive charge patterns created on DNA nanostructures determine cellular uptake efficiency. Nano Lett. 2022;22:5330\u20138. https:\/\/doi.org\/10.1021\/acs.nanolett.2c01316.","journal-title":"Nano Lett"},{"key":"4109_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/SMLL.202003290","author":"L Ding","year":"2020","unstructured":"Ding L, Lyu Z, Louis B, Tintaru A, Laurini E, Marson D, et al. Surface charge of supramolecular nanosystems for in vivo biodistribution: a MicroSPECT\/CT imaging study. Small. 2020. https:\/\/doi.org\/10.1002\/SMLL.202003290.","journal-title":"Small"},{"key":"4109_CR76","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.1021\/JP211041M","volume":"116","author":"G Su","year":"2012","unstructured":"Su G, Zhou H, Mu Q, Zhang Y, Li L, Jiao P, et al. Effective surface charge density determines the electrostatic attraction between nanoparticles and cells. J Phys Chem C. 2012;116:4993\u20138. https:\/\/doi.org\/10.1021\/JP211041M.","journal-title":"J Phys Chem C"},{"key":"4109_CR77","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/J.EURPOLYMJ.2016.09.052","volume":"88","author":"RW Moreadith","year":"2017","unstructured":"Moreadith RW, Viegas TX, Bentley MD, Harris JM, Fang Z, Yoon K, et al. Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson\u2019s disease \u2013 proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications. Eur Polym J. 2017;88:524\u201352. https:\/\/doi.org\/10.1016\/J.EURPOLYMJ.2016.09.052.","journal-title":"Eur Polym J"},{"key":"4109_CR78","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/MDS.28027","volume":"35","author":"CW Olanow","year":"2020","unstructured":"Olanow CW, Standaert DG, Kieburtz K, Viegas TX, Moreadith R. Once-weekly subcutaneous delivery of polymer-linked rotigotine (SER-214) provides continuous plasma levels in Parkinson\u2019s disease patients. Mov Disord. 2020;35:1055\u201361. https:\/\/doi.org\/10.1002\/MDS.28027.","journal-title":"Mov Disord"},{"key":"4109_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115086","author":"S Maher","year":"2023","unstructured":"Maher S, Geoghegan C, Brayden DJ. Safety of surfactant excipients in oral drug formulations. Adv Drug Deliv Rev. 2023. https:\/\/doi.org\/10.1016\/j.addr.2023.115086.","journal-title":"Adv Drug Deliv Rev"},{"key":"4109_CR80","doi-asserted-by":"publisher","unstructured":"Liu P, Viitala T, Kartal-Hodzic A, Liang H, Laaksonen T, Hirvonen J, et al. Interaction studies between\u00a0indomethacin nanocrystals and PEO\/PPO copolymer stabilizers. Pharm Res. 2015;32:628\u201339. https:\/\/doi.org\/10.1007\/S11095-014-1491-3.","DOI":"10.1007\/S11095-014-1491-3"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04109-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04109-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:30:39Z","timestamp":1781537439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04109-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4109"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04109-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.L. is listed as inventor on several patents pertinent to materials used in this study. Furthermore, he is co-founder of DelAQUA Pharmaceutics Inc., which is intent on commercial development of some of the materials used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}